Market Report: Understanding the Future of the Pharma Contract Manufacturing Market 2026

Download your copy of our latest Industry Report to learn about the innovations and trends that are reshaping the sector for 2026 and beyond:

Market Growth: Learn how the global CMO/CDMO market is set to hit $289.68 billion by 2032, driven by biologics and personalised medicine.
Regional Trends: Including why North America leads with over 40% market share and Asia-Pacific shows the fastest growth due to cost advantages.
Innovation Drivers: Such as Artificial Intelligence, Internet of Things and continuous manufacturing, and how they are transforming efficiency and compliance.
Strategic Partnerships: Explore why long-term Pharma-CDMO alliances and digital integration are essential for resilience and agility.
Sustainability Push: Discover how CMOs/CDMOs are adopting green chemistry, renewable energy, and waste reduction to meet their ESG goals.

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: +44 (0) 1135 210 042
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk